Maniatis, A. K., Casella, S. J., Nadgir, U. M., Hofman, P., Saenger, P., Chertok, E., . . . Thornton, P. S. (2021). Efficacy and Safety of up to 2 Years of Treatment With TransCon hGH (Lonapegsomatropin) in Treatment-Naïve and Treatment-Experienced Children With Growth Hormone Deficiency. J Endocr Soc.
Citação norma ChicagoManiatis, Aristides K., et al. "Efficacy and Safety of Up to 2 Years of Treatment With TransCon HGH (Lonapegsomatropin) in Treatment-Naïve and Treatment-Experienced Children With Growth Hormone Deficiency." J Endocr Soc 2021.
MLA citiranjeManiatis, Aristides K., et al. "Efficacy and Safety of Up to 2 Years of Treatment With TransCon HGH (Lonapegsomatropin) in Treatment-Naïve and Treatment-Experienced Children With Growth Hormone Deficiency." J Endocr Soc 2021.